By John Burrill, Product Management Director, Thermo Fisher Scientific
Through the years, advancements in cytogenetics research have improved our understanding of the origins of a variety of genetic diseases and some types of cancer. Recent technological advances in genetic analysis have led to the introduction of high-resolution, genome-wide techniques for chromosomal analysis, such as chromosomal microarray analysis (CMA), exome sequencing (ES), and genome sequencing (GS). With the increased utility of these test methods in clinical research studies, lab directors and clinical scientists face the challenge of determining when to use which method for the best results.
Read more on Labcompare.